Preferred Label : rasburicase;

MeSH note : a recombinant form of enzyme that degrades uric acid to allantoin just downstream of xanthine oxidase; used to treat hyperuricaemia;

CISMeF synonym : elitek; fasturtec; sanofi brand of rasburicase; sanofi synthelabo brand of rasburicase;

MeSH Related Number : EC 1.7.3.3;

Registry Number MeSH : EC 1.7.3.3.; EC 1.7.3.3;

Is substance : O;

UNII : 08GY9K1EUO;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.ema.europa.eu/medicines/human/EPAR/Fasturtec
2012
United Kingdom
English
French
syndication feed
Contraindications, Procedure
gout suppressants
gout suppressants
urate oxidase
hyperuricemia
acute disease
recombinant proteins
hematologic neoplasms
urate oxidase
gout suppressants
treatment outcome
infusions, intravenous
urate oxidase
gout suppressants
pregnancy
breast feeding
urate oxidase
urate oxidase
antiviral agents
drug incompatibility
urate oxidase
drug approval
drug labeling
drug compounding
adult
child
adolescent
rasburicase
rasburicase
gout suppressants
acute kidney injury
urate oxidase
summary of product characteristics
drug evaluation
package leaflet
Contraindications, Drug

---
https://www.cadth.ca/sites/default/files/pdf/108_No45_rasburicase_edrug_f.pdf
2003
Canada
French
hyperuricemia
hyperuricemia
antineoplastic agents
hyperuricemia
child
adult
urate oxidase
rasburicase
rasburicase
urate oxidase
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_243342
2002
France
French
urate oxidase
recombinant proteins
hyperuricemia
adult
child
rasburicase
rasburicase
evaluation of the transparency committee

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.